4//SEC Filing
Hindman Andrew A. 4
Accession 0001415889-22-001699
CIK 0001583107other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:29 PM ET
Size
4.9 KB
Accession
0001415889-22-001699
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2022-02-18$9.61/sh−25,973$249,601→ 481,285 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:29 PM ET
- Size
- 4.9 KB